Biocryst Pharmaceuticals (BCRX) Total Non-Current Liabilities (2010 - 2019)
Biocryst Pharmaceuticals (BCRX) posted Total Non-Current Liabilities of $87.0 million for Q3 2019, down 22.77% on a QoQ basis from $112.6 million in Q2 2019.
Biocryst Pharmaceuticals (BCRX) Total Non-Current Liabilities (2010 - 2019) Analysis & Trends
Biocryst Pharmaceuticals' Total Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $87.0 million for Q3 2019.
- Quarterly Total Non-Current Liabilities changed N/A year-over-year to $87.0 million in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $87.0 million (changed N/A YoY) and the FY2018 annual result came in at $144.1 million, changed N/A from the prior year.
- Total Non-Current Liabilities was $87.0 million for Q3 2019 at Biocryst Pharmaceuticals, down from $112.6 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $144.1 million in Q4 2018 and bottomed at $81.2 million in Q2 2016.
- A 3-year average of $108.8 million and a median of $101.1 million in 2016 frame the typical range for Total Non-Current Liabilities.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 14.92 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 18.28 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.64 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 33.47 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 599.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 20.09 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.24 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.26 Bn |
| 10 | Biocryst Pharmaceuticals | 2.27 Bn | 2.20 Bn | 151.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 86.96 Mn |
| Jun 30, 2019 | 112.60 Mn |
| Mar 31, 2019 | 138.45 Mn |
| Dec 31, 2018 | 144.14 Mn |
| Sep 30, 2016 | 89.60 Mn |
| Jun 30, 2016 | 81.24 Mn |
| Jun 30, 2014 | 139.17 Mn |
| Mar 31, 2014 | 42.41 Mn |
| Dec 31, 2013 | 48.87 Mn |
| Sep 30, 2013 | 51.62 Mn |
| Jun 30, 2013 | 38.24 Mn |
| Mar 31, 2013 | 44.11 Mn |
| Dec 31, 2012 | 52.69 Mn |
| Sep 30, 2012 | 58.56 Mn |
| Jun 30, 2012 | 71.28 Mn |
| Mar 31, 2012 | 76.12 Mn |
| Dec 31, 2011 | 78.21 Mn |
| Sep 30, 2011 | 89.59 Mn |
| Jun 30, 2011 | 106.07 Mn |
| Dec 31, 2010 | 109.45 Mn |